Red Tiger
An obscure ruderalis-influenced strain notable for red and purple foliage, with very little verifiable data behind the marketing.
Red Tiger is a niche strain mostly sold as a curiosity for its red and purple coloration rather than for any documented chemistry or effect profile. There are no peer-reviewed analyses of it, no breeder lab panels in the public record I can verify, and lineage claims vary between sellers. If you're buying it, buy it because you want a pretty plant — not because of any specific effect claim. Treat every potency or terpene number you see on a seed page as marketing until a lab COA proves otherwise.
Overview
Red Tiger is a minor-market cannabis variety sold primarily as a seed novelty by a handful of European seedbanks. Its selling point is visual: leaves and bracts that turn red, pink, or magenta during flowering, sometimes across the whole plant rather than only late in bloom. Outside of seed catalog copy, there is almost no independent documentation of this strain — no peer-reviewed chemotype work, no widely circulated lab COAs, and no significant presence in U.S. dispensary menus. Treat anything written about it, including this article, as provisional. No data
The red coloration itself is real and reproducible in some phenotypes, and is generally attributed to anthocyanin pigments expressed under specific genetic and environmental conditions (cool nights, certain pH ranges, light spectrum). Strong evidence[1] That biology is well understood in plants generally; what is not established is that Red Tiger expresses anthocyanins in a unique or unusually intense way compared to other purple-leaning cultivars.
Chemistry: cannabinoids and terpenes
There is no published, independent chemotype data for Red Tiger that I can verify. No data Seed vendors typically list THC in the 10–15% range and negligible CBD, which is plausible for a ruderalis-influenced hybrid but is not a measurement — it's an estimate, often copied between listings.
No dominant terpene has been reliably reported. Claims you may see online about it being "myrcene-dominant" or "high in pinene" do not, as of this writing, trace back to a lab report. Cannabis terpene profiles vary enormously between phenotypes and grows of the same cultivar Strong evidence[2], so even if one batch were tested, that number wouldn't generalize.
If you grow or buy Red Tiger and get a COA, that single document is more informative than every vendor description combined.
Reported effects
There is no clinical or controlled research on Red Tiger specifically. There is, in fact, no controlled clinical research on any individual cannabis cultivar's subjective effects — strain-level effect claims across the industry are based on user self-report, not trials. Strong evidence[3]
Anecdotal vendor and grower reports describe Red Tiger as a mild, relaxing hybrid without strong sedation, consistent with its modest reported THC. Anecdote Set, setting, dose, tolerance, and your individual endocannabinoid response will swamp any cultivar-specific difference. Anyone telling you a specific strain reliably produces a specific mood is overselling what the evidence supports. Strong evidence[4]
Lineage
Lineage for Red Tiger is disputed and poorly documented. Disputed Some listings describe it as an autoflowering hybrid involving a ruderalis parent crossed with a red/purple-expressing photoperiod line; other listings give no parentage at all. No breeder has, to my knowledge, published a verifiable pedigree with dates, parent IDs, or selection notes.
This is the norm rather than the exception in cannabis. Cultivar names are not regulated, genetic verification is rare, and the same name can refer to genetically distinct plants from different sellers. Strong evidence[5] If lineage matters to you — for breeding, for predicting growth habit, or for chemotype expectations — Red Tiger is not a strain with a paper trail you can rely on.
Cultivation basics
Most Red Tiger seeds sold are autoflowers, meaning they flower based on age rather than photoperiod and finish roughly 8–10 weeks from germination. Vendor descriptions report it as forgiving for beginners, with moderate stretch and indoor yields around 300–400 g/m² under good conditions. These numbers are not independently verified. Weak / limited
To maximize the red coloration that is the whole point of growing this plant, growers commonly drop nighttime temperatures in late flower. Cool nights promote anthocyanin accumulation in many plants, including cannabis. Strong evidence[1] Genetics set the ceiling — a phenotype without the pigment pathway expressed won't turn red no matter how cold you run it — but environment determines how much of that ceiling you hit.
Standard autoflower cautions apply: don't heavily train or top early, don't transplant late, and don't expect a re-veg rescue if something goes wrong. Autos run on a clock.
Marketing vs. reality
Red Tiger sits at the intersection of two things the cannabis market is bad at: novelty color strains and small-batch autoflowers with no public chemistry data. A few honest observations:
- Red leaves don't mean more potency, more flavor, or any specific effect. Anthocyanins are pigments; they are not psychoactive and have no established interaction with cannabinoid effects at smoked doses. Strong evidence[1]
- Vendor THC and yield numbers should be treated as marketing. Without a COA tied to a specific batch, they are estimates at best. Strong evidence[6]
- "Indica" or "sativa" labels for Red Tiger, or any strain, don't reliably predict effects. That folk taxonomy doesn't map cleanly onto modern hybrid genetics or chemotype. Strong evidence[3][4]
If you want a colorful garden plant and you accept that you may end up with a fairly ordinary mild hybrid in terms of smoke, Red Tiger is a reasonable buy. If you want predictable chemistry or effects, buy something with published lab data instead.
Sources
- Peer-reviewed Liu, Y., Tikunov, Y., Schouten, R. E., Marcelis, L. F. M., Visser, R. G. F., & Bovy, A. (2018). Anthocyanin biosynthesis and degradation mechanisms in Solanaceous vegetables: A review. Frontiers in Chemistry, 6, 52.
- Peer-reviewed Richins, R. D., Rodriguez-Uribe, L., Lowe, K., Ferral, R., & O'Connell, M. A. (2018). Accumulation of bioactive metabolites in cultivated medical Cannabis. PLOS ONE, 13(7), e0201119.
- Peer-reviewed Smith, C. J., Vergara, D., Keegan, B., & Jikomes, N. (2022). The phytochemical diversity of commercial Cannabis in the United States. PLOS ONE, 17(5), e0267498.
- Peer-reviewed Piomelli, D., & Russo, E. B. (2016). The Cannabis sativa versus Cannabis indica debate: An interview with Ethan Russo, MD. Cannabis and Cannabinoid Research, 1(1), 44–46.
- Peer-reviewed Schwabe, A. L., & McGlaughlin, M. E. (2019). Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: implications for a budding industry. Journal of Cannabis Research, 1, 3.
- Peer-reviewed Jikomes, N., & Zoorob, M. (2018). The cannabinoid content of legal cannabis in Washington State varies systematically across testing facilities and popular consumer products. Scientific Reports, 8, 4519.
How this page was made
Generation history
Drafting assistance and fact-check automation are used, with a human operator spot-checking on a weekly basis. See how articles are made.